Dewmar International BMC, Inc. (DEWM) Becomes Current in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
120
Dewmar International BMC, Inc. (DEWM) Becomes Current in their OTC Market Filings

HOUSTON, TX--(Marketwired - Jun 22, 2017) - Dewmar International BMC, Inc. ( OTC PINK : DEWM ), a diversified operating company that conducts business across variegated business sectors including consumer goods, hemp, cannabis, pharmaceuticals and healthcare announced today that OTC Markets has accepted its Financial Disclosure Statements and listed the company as Pink Current.

Over the past two weeks, Dewmar has filed with OTC Markets annual financial reports from 2014 to 2016 and Q1 2017.

FINANCIAL HIGHLIGHTS FROM THIS 3 YEAR FILING PERIOD INCLUDE:

  • There has not been any new convertible debt financing since 2013
  • The business is currently self-funding all daily operations
  • Business expansion into the healthcare market grew 2014 annual revenue to over $4,000,000
  • The Company sustained annual revenue over $3.3 million in 2015
  • Market wide changes in healthcare trimmed 2016 annual revenue to $630,000
  • The Company reinvested previous years' profits into new product development, acquisitions, new businesses developments, personnel training and healthcare technologies to name a few of many more items.
  • As of March 31, 2017, Dewmar International has $3.8 million is assets on its Balance Sheet, not including its market cap

MAJOR OPERATIONAL HIGHLIGHTS FROM THE FILING PERIOD INCLUDE:

  • In early 2014, Dewmar International formed United States Hemp Corporation (USHC) , a wholly owned subsidiary, based out of Denver, CO to focus on emerging opportunities in both the hemp and cannabis industries resulting from sweeping legislation changes occurring on the State level across the entire country. USHC has a hemp/cannabis business incubator program to discover emerging brands, services and technologies to assist them in major channel distribution.
  • In late 2014, the Company formed Health & Wellness Research Consortium (HWRC), LLC as a wholly owned subsidiary, to develop and market non-opioid, alternative therapies used to treat acute or chronic pain management.
  • On 4/20 2015, the Company contracted with a bakery in Colorado to manufacture infused hemp baked goods under the Federally trademarked brand name Kush Cakes , which is legal for distribution in all 50 states.
  • In 2016 the Company further expanded its infused baked goods contract to a more advanced Arizona bakery with intentions to partner with its Arizona affiliate to create a series of THC:CBD infused medicinal edibles.
  • In 2017, Dewmar's brand management division gained product expansion across an expanded 3 state territory to a record number of Walmart Supercenters and Walmart Neighborhood Markets for its flagship brand Lean Slow Motion Potion. The Company has immediate plans for a heightened marketing and advertising campaign for the remainder of 2017.

"I'm extremely proud of the work that we have done over the past few years to eliminate all toxic funding from our balance sheet, grow the company's revenue base by successfully expanding into new markets and reinvesting profits into the business -- primarily within the healthcare sector -- that should lead to sustainable long-term growth," stated founder & CEO, Dr. Marco Moran.

The Company's Board hopes that its investors will take the time to review recent filings that provide insightful information on company activity, market developments and financial results.

Dr. Moran concluded, "Stay tuned, because we have more exciting news that we will be releasing very soon, particularly giving detailed information about the diverse portfolio of businesses that the Company has invested in over the past 2 years which all have a synergistic effect to yield high returns for the Company."

About Dewmar International BMC, Inc.   Dewmar International BMC, Inc. is a U.S. based new product development, manufacturing and brand management company. Established in 2003, Dewmar's primary business strategy has been in creating high profit margins with functional foods and beverages, as well as introducing new simple yet meaningful innovations to markets of great demand. The Company's flagship product, Lean Slow Motion Potion™, whose flavors include Yella, Purp and Easta Pink, is rated as one of the top 3 national selling relaxation beverages in the U.S. market. The company has offices in Clinton, MS; Houston, TX: Denver, CO and New Orleans, LA.

Click here for the Safe Harbor Statement.

Dewmar International BMC, Inc. Investment & Company Information InvestorRelations@DewmarInternational.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 4

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Alliance Introduces Game-Changing Tools and Expands

Updated Category News Views 289

AI Alliance Launches Innovative Programming Language and Framework Today marked a significant advancement in the world of artificial intelligence as the AI Alliance, a global non-profit organization committed to the evolution of open-source AI, unveiled groundbreaking initiatives. The introduction of Dana, an AI-powered programming language, alongside the OpenDXA agent...

Continue Reading
FDA Approves Repatha for Adults with High LDL-C Risks

Updated Category News Views 245

FDA Broadens Repatha Approval for Cardiovascular Risk Recently, the FDA has expanded the therapeutic indications for Repatha (evolocumab), allowing it to be prescribed to adults at a heightened risk of major adverse cardiovascular events (MACE) due to uncontrolled low-density lipoprotein cholesterol (LDL-C), often referred to as 'bad cholesterol.' This significant update...

Continue Reading
Nikola Corp Strengthens Financial Strategy with Updated Equity Deal

Updated Category News Views 116

Nikola Corporation's Strategic Financial Update Nikola Corporation (NASDAQ:NKLA), renowned for its commitment to zero-emission vehicle manufacturing, has made significant adjustments to its equity distribution agreement with Citigroup Global Markets Inc. This change was detailed in a recent filing, affirming the company's proactive approach to managing its financial...

Continue Reading
Exploring the Future of the Emergency Food Market Growth

Updated Category News Views 243

Understanding the Emergency Food Market Expansion The global emergency food market is on the brink of a significant transformation as it is projected to grow by an impressive USD 3.20 billion over the period from 2024 to 2028. With a compound annual growth rate (CAGR) of approximately 7.35%, this market is witnessing a shift driven by the organized retail sector's growth...

Continue Reading
Innovative Robotics: KEENON Launches Humanoid and Lawn Mower

Updated Category News Views 166

KEENON Robotics Makes Waves at CES with New Innovations At the recent tech event, KEENON Robotics, a pioneer in the field of service robotics, took center stage by unveiling its latest creations: the humanoid robot XMAN-R1 and the fully autonomous lawn mower known as KEENMOW K1. This showcase reflects KEENON's commitment to innovation and its mission to improve everyday...

Continue Reading